Armistice Capital, LLC Eledon Pharmaceuticals, Inc. Transaction History
Armistice Capital, LLC
- $7.34 Billion
- Q1 2024
A detailed history of Armistice Capital, LLC transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 2,297,000 shares of ELDN stock, worth $5.47 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,297,000
Previous 2,189,000
4.93%
Holding current value
$5.47 Million
Previous $3.94 Million
20.08%
% of portfolio
0.06%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding ELDN
# of Institutions
32Shares Held
9.61MCall Options Held
500Put Options Held
1.4K-
Bvf Inc San Francisco, CA4.33MShares$10.3 Million0.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA969KShares$2.31 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA652KShares$1.55 Million0.01% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT443KShares$1.05 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA181KShares$430,5440.0% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $32.7M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...